Literature DB >> 27355861

Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.

Judit Alarcón-Millán1, Gloria Fernández-Tilapa2, Enoc Mariano Cortés-Malagón3, Carlos Alberto Castañón-Sánchez4, José De Sampedro-Reyes5, Iván Cruz-Del Carmen6, Reyes Betancourt-Linares7, Adolfo Román-Román8.   

Abstract

In developing countries, clarithromycin resistance and frequency of re-infection are factors that contribute to high prevalence of Helicobacter pylori infection. The aim of this research was determine the prevalence of clarithromycin resistance and its relation with A2142G, A2142C and A2143G mutations in the domain V of the 23S rRNA gene of H. pylori isolates in patients from Southern Mexico with chronic gastritis. Another purpose of this work was to study the prevalence of virulent genotypes and distribution of resistant strains according to the vacA/cagA/babA2 H. pylori genotypes. One hundred forty-four patients with chronic gastritis were studied. Forty-five H. pylori strains were isolated and clarithromycin susceptibility was determined by the disk-diffusion method. The 82.2% of the strains had the combination of alleles vacA s1 m1 and the cagA gene was detected in 77.8% and 40% of the strains were babA2 positive. The vacA s1 m1 genotype was detected more frequently in cagA(+) strains, vacA s1m1/cagA(+)/babA2(-) genotype was more frequent than vacA s1m1/cagA(+)/babA2(+), 37.8% and 33.3%, respectively. Eight strains were clarithromycin resistant, in three of these, point mutations were identified, but only in one strain the A2143G mutation associated with clarithromycin resistance was found. Other point mutations (A1821G, G1826A, T1830C, A2089G, T1600C, C1601T, C1602T, T1610C, A1611C and T1633G) that have not been associated with clarithromycin resistance were identified. The highest proportion of resistant strains was vacA s1m1/cagA(+) (62.5%). In patients from southern Mexico with chronic gastritis, the prevalence of clarithromycin resistance is within internationally accepted range (17.8%) and allows continued use of triple therapy for H. pylori eradication. However, it is necessary to monitor the evolution of clarithromycin resistance in this area. The largest proportion of resistant H. pylori strains is not harboring the A2142G, A2142C and A2143G mutations in the 23S rRNA gene (87.5%). The vacA s1m1/cagA(+) genotype was the most prevalent and among clarithromycin-resistant strains, this was the predominant.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clarithromycin; Disk-diffusion; Helicobacter pylori; Resistance; Virulence genotypes

Mesh:

Substances:

Year:  2016        PMID: 27355861     DOI: 10.1016/j.meegid.2016.06.044

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

1.  Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study.

Authors:  Chuanfeng Zhang; Mengjiao Cao; Tangshan Lv; Hongyan Wang; Xiaoxiao Liu; Yong Xie; Nonghua Lv; Hongtan Chen; David S Cram; Jing Zhong; Linfu Zhou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-01       Impact factor: 3.267

2.  Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.

Authors:  Mohsen Karbalaei; Amin Talebi Bezmin Abadi; Masoud Keikha
Journal:  BMC Infect Dis       Date:  2022-06-25       Impact factor: 3.667

3.  Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients' Stomachs.

Authors:  Shadiyeh Khani; Amin Talebi Bezmin Abadi; Ashraf Mohabati Mobarez
Journal:  Infect Drug Resist       Date:  2019-11-01       Impact factor: 4.003

4.  Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México.

Authors:  Margarita Camorlinga-Ponce; Alejandro Gómez-Delgado; Emmanuel Aguilar-Zamora; Roberto C Torres; Silvia Giono-Cerezo; Antonio Escobar-Ogaz; Javier Torres
Journal:  Front Cell Infect Microbiol       Date:  2021-02-11       Impact factor: 5.293

5.  Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori.

Authors:  Xiao-Hua Li; Yong-Yi Huang; Lin-Ming Lu; Li-Juan Zhao; Xian-Ke Luo; Ru-Jia Li; Yuan-Yuan Dai; Chun Qin; Yan-Qiang Huang; Hao Chen
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

6.  Different dose of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysis.

Authors:  Wenwen Gao; Xiang Zhang; Yanhui Yin; Shuwen Yu; Lu Wang
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 7.  Helicobacter pylori infection causes both protective and deleterious effects in human health and disease.

Authors:  Anna K Miller; Scott M Williams
Journal:  Genes Immun       Date:  2021-07-09       Impact factor: 2.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.